PHAGEinLYON Clinic Cohort Study: a Descriptive Study of Severe Infections Treated With Phage Therapy at the HCL.

Severe Infection Clinical Trial

Official title:

Non Interventional Retrospective and Prospective Single Center Descriptive Study of Severe Infections Treated With Phage Therapy at the Hospices Civils de Lyon (PHAGEinLYON Clinic Cohort Study).

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06185920
• Other study ID #: 69HCL23_0189
• Status: Recruiting
• Start date: February 1, 2023
• Est. completion date: February 1, 2034

Study information

• Verified date: December 2023
• Source: Hospices Civils de Lyon
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

PHAGEinLYON Clinic cohort study is a single site non-interventional retrospective and prospective study, initiated by the Hospices Civils de Lyon. Population targeted are patients with a severe infection treated with bacteriophage in the Hospices civils de Lyon from 2015 to 2033. The primary objective is to describe the severe infections treated with phagotherapy. 250 patients will be included in the study.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 250
• Est. completion date: February 1, 2034
• Est. primary completion date: February 1, 2033
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Patient with severe infection treated with bacteriophage in the Hospices Civils de Lyon from 01/01/2015 to 01/01/2033
• PHAGEinLYON Clinic cohort study information notice provided to the patient

Exclusion Criteria:

• Opposition of trial participant

Related Conditions & MeSH terms

• Communicable Diseases
• Infections
• Severe Infection

Intervention

Other:
• Description of severe infection
Description of severe infections treated with bacteriophage in the Hospices Civils de Lyon from 2015 to 2033.

Locations

Country	Name	City	State
France	Department of Infectious and Tropical Diseases of the Croix Rousse Hospital of the Civil Hospitals of Lyon	Lyon

Sponsors (1)

Lead Sponsor	Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Rate of each type of severe infection	Rate of each type of severe infection treated with bacteriophage in the Hospices Civils de Lyon from 2015 to 2033.	through study completion (5years)